Printer Friendly

P&G Grants Glaxo Licensing Rights To Its Ulcer Drug Technology

CINCINNATI, Nov. 25 /PRNewswire/ -- The Procter & Gamble Company (NYSE: PG) has granted a worldwide license to Glaxo Wellcome (NYSE: GLX), involving four patents for P&G's ulcer eradication drug technology.

This agreement enables Glaxo Wellcome to sell certain ulcer drug therapies worldwide. In return, Glaxo Wellcome will make payments to P&G based on sales of Glaxo Wellcome's H. pylori treatment products in countries where P&G has valid patents.

Glaxo Wellcome now markets ranitidine bismuth citrate, known as Tritec(R) and Pylorid(TM), in combination with anti-infectives for the treatment of duodenal ulcer disease caused by H. pylori.

Glaxo Wellcome started marketing the product known as Tritec in the U.S. and Pylorid in the U.K. earlier this year, while finalizing terms of this licensing agreement with P&G.

P&G's Helidac(TM) Therapy combines three drugs: bismuth subsalicylate, metronidazole and tetracycline hydrochloride. Helidac Therapy, when used with an H-2 antagonist, is indicated for patients with active duodenal ulcer disease associated with H. pylori infection.

Helidac Therapy itself is not being licensed to Glaxo.

SOURCE The Procter & Gamble Company
 -0- 11/25/96


/NOTE TO EDITORS: This is the second release on P&G's Helidac Therapy -- the first release was issued earlier today (11/25) at 9:45 a.m. EST./

/CONTACT: Jim Schwartz, Public Relations, of The Procter & Gamble Company, 513-945-8055/

(PG GLX)

CO: The Procter & Gamble Company; Glaxo Wellcome ST: Ohio IN: HOU MTC SU: LIC

BG-CS -- CLM017 -- 3672 11/25/96 11:14 EST http://www.prnewswire.com
COPYRIGHT 1996 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 25, 1996
Words:253
Previous Article:Genesis' CE0 Announces Quota-Share Agreement with Second Largest Insurance Company In Central America
Next Article:Marriott Distribution Services Awarded Boston Market and Einstein/Noah Bagel Corporation Contract
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters